scispace - formally typeset
F

Fengyan Yu

Researcher at Sun Yat-sen University

Publications -  27
Citations -  4319

Fengyan Yu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Breast cancer & Metastasis. The author has an hindex of 17, co-authored 24 publications receiving 3996 citations. Previous affiliations of Fengyan Yu include Harvard University.

Papers
More filters
Journal ArticleDOI

let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells

TL;DR: Let-7 regulates multiple BT-IC stem cell-like properties by silencing more than one target, and miRNA expression in self-renewing and differentiated cells from breast cancer lines and in breast T-IC and non-BT-IC from 1 degrees breast cancers is compared.
Journal ArticleDOI

miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases

TL;DR: Expression of miR-200, which promotes a mesenchymal to epithelial cell transition (MET) by inhibiting Zeb2 expression, unexpectedly enhances macroscopic metastases in mouse breast cancer cell lines, suggesting that for some tumors, tumor colonization at metastatic sites might be enhanced by MET.
Journal ArticleDOI

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

TL;DR: The data suggest mir-30 as one of the important miRNAs in regulating the stem-like features of T-ICs, which have a pivotal role in tumorigenesis, tumor progression, metastasis and post-treatment relapse.
Journal ArticleDOI

Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5

TL;DR: Reduction in miR-128 leading to Bmi-1 and ABCC5 overexpression is a stem cell–like feature of BT-ICs, which contributes to chemotherapeutic resistance in breast cancers.